pharmacy services sector
TRANSCRIPT
![Page 1: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/1.jpg)
Industry StudyPharmacy Services
![Page 2: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/2.jpg)
Introducing the Industry
• Pharmacy Services industry falls within the Healthcare and Consumer Non-Cyclicals
• Healthcare has a relatively high valuation and returns as compared to the S&P
![Page 3: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/3.jpg)
Introducing the Industry
• S&P has company and industry studies• S&P calls this industry Drug Retail and
has it listed under Consumer Staples sector
• Morningstar has it under Healthcare sector
• Value Line has it under Healthcare sector
• CVS and WGA are conglomerates (pharmacy, clinics, drug plans)
![Page 4: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/4.jpg)
Introducing the Industry
• S&P company reports, provides a one page description of the industry outlook
• Value Line also has industry reports
![Page 5: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/5.jpg)
Introducing the Industry
• To get a good picture of this industry, just google it. • “Health Care Plans Industry” or “Pharmaceutical Services”• You will get a plethora of opinions and analysis of this industry• After reading several, you will get a good general picture of
the industry• S&P has industry studies of about 60+pgs but you have to pay
for them
![Page 6: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/6.jpg)
Industry Findings
After researching, jot down a few “take-aways”…• Aging baby boomers and increase in insured boost prescription
drugs• Very competitive• Low margins• Many large mature companies that pay dividends• Merger and acquisitions taking place to grow operations and
earnings
![Page 7: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/7.jpg)
Identifying Competitors
• Used Value Line and Standard and Poors because Morningstar and Finviz had CVS in with Health Care Plan industry.
• Better Investing also has studies that can be used to find promising competitors: Ticker Talk, First Cut, StockUp, Magazine
![Page 8: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/8.jpg)
Narrowing Competitor List
I would typically use Finviz and screen these variables…• Sector – XXXX • Industry – YYYY• Short Float - < 15%• PEG < 2• ROE > 10%• You can also use Sales and EPS growth rates and PTP Margin to
narrow the list
![Page 9: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/9.jpg)
Narrowing Competitor List
But CVS is not a strict pharma, so I added additional companies from Value Line in the screener…• I manually added these: GNC, WBA, CVS, BIOS, ESRX, OCR, PETS, PMC, RAD• Sector – I did not use this feature • Industry – I did not use this feature• Short Float - < 15%• PEG < 2• ROE > 10%
![Page 10: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/10.jpg)
Narrowing Competitors to Study
http://finviz.com/screener.ash
Results• CVS• GNC• WBA• ESRX – had a PEG > 2
![Page 11: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/11.jpg)
Lets Start our Study
![Page 12: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/12.jpg)
SSG Section 1: Visual Analysis (Sales/EPS/Price)
Select companies with sales and EPS stats that are: Up Straight Parallel
![Page 13: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/13.jpg)
Would you throw any out?
CVS WBA
GNC ESRX
Annual Numbers
![Page 14: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/14.jpg)
Would you throw any out?
WBA
GNC
Zero Percent Return Line
CVS
ENSX
Quarterly Numbers
![Page 15: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/15.jpg)
Sales/Earnings Forecast Summary – Value Line, Morningstar, Zachs, BIYear WBA GNC ESRX CVS
Sales ($/share) EPS
Sales ($/share) EPS Sales ($/share) EPS
Sales ($/share) EPS
2011 81.17 2.64 20.31 1.24 70.52 5.21 82.51 2.82012 75.88 2.53 24.49 2.29 114.73 1.79 100.03 3.432013 76.29 2.61 27.99 2.72 134.56 2.31 107.42 42014 80.41 2.9 29.58 2.81 138.94 2.64 122.25 4.512015 101.4 3.65 31.65 3.05 150.35 3.25 133.75 5.15est. 2018 to 2020 152.85 6.1 41.25 4.75 159.35 5.65 176.9 7.2 CAGR (%) - 2011 to 2019 10.1 13.0 7.9 12.5 5.9 8.9 9.0 11.3CAGR (%) - 2013 to 2019 12.2 14.8 6.8 10.7 2.4 15.6 7.9 9.6VL % Growth (2018-20) 12.0 15.0 7.5 10.5 6.0 16.0 8.5 11.0BI Preferred Procedure 11.8 8.8 14.7 7.0 Morningstar 5 yr est. 24.9 11.5 36.6 17.1Zachs 5 yr est. 11.9 11.3 12.6 13.3Yahoo 5 yr est. 14.7 12.0 13.0 Yahoo 1 yr est. 17.8 4.1 2.9 Morningstar 2 yr est. 3.1 9.5 7.3 5.5 What I used 9 11.4 9.5 8.3 13 14.7 7 7.3
CAGR = Compound Annual Growth Rate
![Page 16: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/16.jpg)
SSG Section 2: Evaluating Management
Management Quality Measures% Pretax Profit on Sales = Net Income Before Taxes/Net
Sales % Return on Equity = Net Income After Taxes /
Shareholder Equity
% Debt to Capital
![Page 17: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/17.jpg)
Return on Equity, Pretax Profit on Sales, and Debt to Capital
CVS
GNC
ENSX
WBA
![Page 18: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/18.jpg)
SSG Section 2: Evaluating Management
• GNC has the best pretax profit and is about twice as high as the others• GNC and ESRX return on equity is about twice as high as the others• GNC and ESRX have twice the debt as the others as well (>40%), this is
probably why both have higher ROE• BI generally recommends staying away when % Debt to Capital is > 30%• Interest coverage ratio: ESRX = 6.3, GNC = 9.7; Red Flag (recommend
> 7 or 8) • Drop ESRX from further consideration until their debt is more
manageable
![Page 19: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/19.jpg)
SSG Section 3:Price and Earning History
• We do not want to buy an overpriced stock • PE fluctuates based on investor sentiment and market conditions• Use price and earnings history to forecast high and low stock
price• BI includes a 5-yr table with this information; may want to go
back further • Our goal is to strike the outliers so they are not used in our price
forecasts
![Page 20: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/20.jpg)
SSG Section 3:Price and Earning History
I don’t plan to strike the high PE. Competitor, WBA, had very high PEs about 10 years ago. They are going up.
CVS
![Page 21: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/21.jpg)
SSG Section 3:Price and Earning History
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
WAB 43.3 38.1 46.4 36.8 27.7 26.3 27.9 26 22.2 17.1 13.9 15.9 14.8 13.2 16.3 21.8
GNC 18.2 15.6 17.6 14.9
CVS 19.6 19.3 19.1 15 12 12.1 12.9 13.2 14.7 17.4
I don’t plan to strike the CVS high PE. Competitor, WBA, had very high PEs about 10 years ago.
![Page 22: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/22.jpg)
Price and Earnings History
GNC
WBA
![Page 23: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/23.jpg)
SSG Section 4:Risk and Reward
• Now we use our P/E history to forecast our high and low prices• Our forecasts are for a full market cycle which may be longer
than 5 years• Remember, the market may be topping right now, especially the
health care sector• You may be buying right before a correction and have to wait for
the next top
![Page 24: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/24.jpg)
Forecasting High Price
• Current P/E is high compared to the 5-year avg. high. Use the 5yr avg. high.
• High EPS comes from Section 1 of the SSG, 5 years out (it grows for growth companies).
![Page 25: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/25.jpg)
Forecasting Low Price
• These three companies are mature companies• They are not fast growers given their sales (<10% per year)• They all pay a nice dividend as a way to reward shareholders• Income investors like these types of companies, they add stability to
their portfolio and pay them to wait for the incremental increase of stock price
• As such, investors will buy them up when the dividend yield is high. • As such, yield investors provide low or bottom price support.
![Page 26: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/26.jpg)
• I selected the last option (price dividend will support). I depend on income investors to provide a solid bottom price support.
![Page 27: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/27.jpg)
Zoning
• I will use our high and low price forecasts for a buy and sell strategy
• BI uses a zoning method for providing buy and sell signals. CVS is a sell right now but you can use the buy price as a pounce price (buy when its reached)
![Page 28: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/28.jpg)
Upside Downside Ratio
• BI provides a way to estimate the reward and risk of owning a stock
• USDS ratio for CVS (below) is invalid because the forecast high is below the current price; it’s a fully valued stock
• BI recommends waiting until it reaches a 3 to 1. If you do this, for every under performer, you will have a over performer, the rest will meet your 15% annual appreciation goal.
![Page 29: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/29.jpg)
Price Target
• The price target for CVS is down. I do not expect the price to increase• Some analysts contradict this because CVS recently bought Omnicare
and Target pharmacies to increase value beyond the data that is available to me.
• I do not have the expertise to put a valuation on this…• S&P value it at $126/share in 12 months rather than my $103 in the
next 5 years.
![Page 30: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/30.jpg)
SSG Section 5:5 Year Potential Return Average annual return
is essentially less than the dividend.
There is no P/E expansion expected unless they do something (look at SSG graph of the price and earnings)
![Page 31: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/31.jpg)
CVS
WBA
![Page 32: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/32.jpg)
Stock Comparison Guide
• Used to compare companies• Companies should be in the
same industry and similar• CVS and WBA are very similar
pharmaceutical companies• GNC is more of a vitamin
retailer
![Page 33: Pharmacy Services Sector](https://reader036.vdocuments.net/reader036/viewer/2022070600/58e4ab211a28abbb038b5617/html5/thumbnails/33.jpg)
Industry Study Take-Aways
• Industry is overpriced right now for expected earnings (just look at the SSG sales and earnings graph); however, M&A is expected to produce growth.
• Industry has a few big players; they are large, mature companies• CVS and WBA were hard to put a valuation on since they are
conglomerates and have been using M&A to grow. • Both also have clinics and provide drug plans• Mergers and acquisitions are occurring to increase revenue and earnings• Could use the studies low price for the pounce list